NSE Antibodies

Santa Cruz Biotechnology features a diverse variety of NSE Antibodies, specifically targeting neuron-specific enolase (NSE). NSE Antibodies are effective tools in various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Neuron-specific enolase is a glycolytic enzyme that plays a crucial role in energy metabolism within neurons and neuroendocrine cells. As a biomarker for neuronal damage, NSE has significant implications in various neurological disorders, making it a key focus in neurobiology and cancer research. The accurate detection and quantification of NSE enables researchers to better understand cellular mechanisms in both normal and pathological conditions. Monoclonal NSE antibodies support detailed analysis of neuronal development, function, and response to injury. Advanced research techniques utilizing NSE detection contribute to expanding knowledge about neurological conditions and potential therapeutic approaches. The reliability and specificity of Santa Cruz Biotechnology monoclonal NSE antibodies continue to advance scientific understanding of neuronal biology and pathology.